CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

Name: CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial
License: Public Domain

Institute of Hematology and Blood Transfusion, Czech Republic

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

leukemia myeloid

leukemia, myeloid, acute(aml), precursor cell lymphoblastic leukemia-lymphoma, myelodysplastic syndromes (mds), blastic plasmacytoid dendritic cell neoplasm (bpdcn)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 226247
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.